Bluejay Diagnostics Inc (BJDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,165 | 4,302 | 2,209 | 10,115 | 19,048 |
| Other current assets | 23 | 0 | 265 | 0 | 0 |
| TOTAL | $5,464 | $4,899 | $3,221 | $11,789 | $20,661 |
| Non-Current Assets | |||||
| PPE Net | 1,534 | 1,514 | 1,286 | 1,232 | 337 |
| Other Non-Current Assets | 121 | 245 | 362 | 501 | 21 |
| TOTAL | $1,656 | $1,759 | $1,648 | $1,733 | $358 |
| Total Assets | $7,119 | $6,657 | $4,869 | $13,521 | $21,019 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 214 | 145 | 492 | 636 | 296 |
| Accrued Expenses | 805 | 552 | 1,117 | 836 | 341 |
| TOTAL | $1,119 | $810 | $1,771 | $1,640 | $637 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 25 | 118 | 202 | 340 | 0 |
| TOTAL | $25 | $118 | $202 | $340 | $N/A |
| Total Liabilities | $1,144 | $928 | $1,974 | $1,980 | $637 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 972 | 139 | 2 | 1 | 1 |
| Common Shares | 0 | 0 | N/A | 0 | 2 |
| Retained earnings | -41,517 | -34,669 | -26,951 | -16,997 | -7,695 |
| TOTAL | $5,975 | $5,730 | $2,895 | $11,541 | $20,382 |
| Total Liabilities And Equity | $7,119 | $6,657 | $4,869 | $13,521 | $21,019 |